The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease

por Horna, Pedro, King, Rebecca L., Jevremovic, Dragan, Fajgenbaum, David C., Dispenzieri, Angela
Publicado 2022

Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma

por Prada, Libardo Rueda, Gavrancic, Tatjana, Cadena Sanabria, Miguel O., Dumic, Igor, Bourgeois, Kirk, King, Rebecca L., Yan, Yiyi
Publicado 2023

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells

por Abeykoon, Jithma P., Paludo, Jonas, Nowakowski, Kevin E., Stenson, Mary J., King, Rebecca L., Wellik, Linda E., Wu, Xiaosheng, Witzig, Thomas E.
Publicado 2019

Amyloid arthropathy in smoldering myeloma: Do not take it lightly

por Muchtar, Eli, King, Rebecca L., McPhail, Ellen D., Thorpe, Matthew P., Gonsalves, Wilson, Ernste, Floranne, Grogan, Martha, Dispenzieri, Angela, Gertz, Morie A.
Publicado 2021

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era

por King, Rebecca L., Nowakowski, Grzegorz S., Witzig, Thomas E., Scott, David W., Little, Richard F., Hong, Fangxin, Gascoyne, Randy D., Kahl, Brad S., Macon, William R
Publicado 2018

Bone Marrow Biopsy Operator Experience and Impact on Aspirate, Biopsy, and Ancillary Testing Quality

por Marinelli, Lisa M., Fang, Hong, Howard, Matthew T., Hanson, Curtis A., Haack, Joseph J., Eick, Edward A., Allen, Richard J., Ruffridge, David E., Byrne, Colleen M., King, Rebecca L.
Publicado 2018

High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?

por Pophali, Priyanka A., Marinelli, Lisa M., Ketterling, Rhett P., Meyer, Reid G., McPhail, Ellen D., Kurtin, Paul J., Mwangi, Raphael, Maurer, Matthew J., Habermann, Thomas, King, Rebecca L.
Publicado 2020

MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma

por Gagnon, Marie-France, Pearce, Kathryn E., Greipp, Patricia T., Xu, Xinjie, Hoppman, Nicole L., Ketterling, Rhett P., McPhail, Ellen D., King, Rebecca L., Baughn, Linda B., Peterson, Jess F.
Publicado 2021

Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma

por Dalland, Joanna C., Smadbeck, James B., Sharma, Neeraj, Meyer, Reid G., Pearce, Kathryn E., Greipp, Patricia T., Peterson, Jess F., Kumar, Shaji, Ketterling, Rhett P., King, Rebecca L., Baughn, Linda B.
Publicado 2021

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

por Castellino, Alessia, Tun, Aung M., Wang, Yucai, Habermann, Thomas M., King, Rebecca L., Ristow, Kay M., Cerhan, James R., Inwards, David J., Paludo, Jonas, Ansell, Stephen M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2021

Epstein Barr Virus–Negative Lymphoplasmacytic Proliferation Limited to the Renal Allograft: A Unique Presentation of a Rare Disease

por D’Costa, Matthew R., King, Rebecca L., Alexander, Mariam P., Zhang, Pingchuan, Issa, Naim, Dingli, David, Amer, Hatem, Singh, Devender, Leung, Nelson, Sukov, William R., Dean, Patrick G., Habermann, Thomas M., Kukla, Aleksandra
Publicado 2021

Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymph...

por Desai, Sanjal H., LaPlant, Betsy, Macon, William R., King, Rebecca L., Wang, Yucai, Inwards, David J., Micallef, Ivana, Johnston, Patrick B., Porrata, Luis F., Ansell, Stephen M., Habermann, Thomas M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2021

Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era

por Arushi Khurana, Mwangi, Raphael, Ansell, Stephen M., Habermann, Thomas M., Cerhan, James R., Strouse, Christopher, Link, Brian K., Wang, Yucai, King, Rebecca L., Macon, William R., Villasboas, J. C., Witzig, Thomas E., Maurer, Matthew J., Nowakowski, Grzegorz S.
Publicado 2021

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

por Desai, Sanjal H., Mwangi, Raphael, Ng, Wern Lynn, King, Rebecca L., Maurer, Matthew J., Cerhan, James R., Feldman, Andrew L., Farooq, Umar, Mou, Eric, Habermann, Thomas M., Thompson, Carrie A., Wang, Yucai, Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

por Desai, Sanjal H., Mwangi, Raphael, Smith, Alexandra N., Maurer, Matthew J., Farooq, Umar, King, Rebecca L., Cerhan, James R., Feldman, Andrew L., Habermann, Thomas M., Thompson, Carrie A., Wang, Yucai, Ansell, Stephen M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients

por Krull, Jordan E., Wenzl, Kerstin, Hartert, Keenan T., Manske, Michelle K., Sarangi, Vivekananda, Maurer, Matthew J., Larson, Melissa C., Nowakowski, Grzegorz S., Ansell, Stephen M., McPhail, Ellen, Habermann, Thomas M., Link, Brian K., King, Rebecca L., Cerhan, James R., Novak, Anne J.
Publicado 2020

Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria

por King, Rebecca L., Khurana, Arushi, Mwangi, Raphael, Fama, Angelo, Ristow, Kay M., Maurer, Matthew J., Macon, William R., Ansell, Stephen M., Bennani, N. Nora, Kudva, Yogish C., Walker, Randall C., Watt, Kymberly D., Schwab, Thomas R., Kushwaha, Sudhir S., Cerhan, James R., Habermann, Thomas M.
Publicado 2021

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

por Desai, Sanjal H., Pederson, Levi, LaPlant, Betsy, Mwangi, Raphael, Maurer, Matthew, Young, Jason R., Macon, William R., King, Rebecca L., Wang, Yucai, Cerhan, James R., Feldman, Andrew, Inwards, David J., Micallef, Ivana, Johnston, Patrick, Porrata, Luis F., Ansell, Stephen M., Habermann, Thomas M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

por King, Rebecca L., Gupta, Alia, Kurtin, Paul J., Ding, Wei, Call, Timothy G., Rabe, Kari G., Kenderian, Saad S., Leis, Jose F., Wang, Yucai, Schwager, Susan M., Slager, Susan L., Kay, Neil. E., Koehler, Amber, Ansell, Stephen M., Inwards, David J., Habermann, Thomas M., Shi, Min, Hanson, Curtis A., Howard, Matthew T., Parikh, Sameer A.
Publicado 2022

Targeting of Inflammatory Pathways with R2CHOP in High-Risk DLBCL

por Hartert, Keenan T., Wenzl, Kerstin, Krull, Jordan E., Manske, Michelle, Sarangi, Vivekananda, Asmann, Yan, Larson, Melissa C., Maurer, Matthew J., Slager, Susan, Macon, William R., King, Rebecca L., Feldman, Andrew L., Gandhi, Anita K., Link, Brian K., Habermann, Thomas M., Yang, Zhi-Zhang, Ansell, Stephen M., Cerhan, James R., Witzig, Thomas E., Nowakowski, Grzegorz S., Novak, Anne J.
Publicado 2020